Home/Filings/4/0000914190-19-000501
4//SEC Filing

Mieyal Paul A 4

Accession 0000914190-19-000501

CIK 0001196298other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 5:09 PM ET

Size

7.7 KB

Accession

0000914190-19-000501

Insider Transaction Report

Form 4
Period: 2019-12-16
Transactions
  • Award

    Common Stock

    2019-12-16+3,4483,448 total
  • Award

    Stock Option (Right to Buy)

    2019-12-16+5,5685,568 total
    Exercise: $8.57Exp: 2029-12-16Common Stock (5,568 underlying)
Footnotes (2)
  • [F1]On December 16, 2019, the Company granted 3,448 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Mieyal in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date.
  • [F2]On December 16, 2019, the Company granted an option to purchase 5,568 shares of common stock of the Company (the "Option") in respect of the service by Mr. Mieyal as a member of the Board of Directors of the Company. The Option was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Option was granted to Wexford Capital LP. The Option vests as to 1,856 shares on each of 12/16/19, 12/16/20 and 12/16/21.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001412471

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:09 PM ET
Size
7.7 KB